Vr Adviser, LLC Oric Pharmaceuticals, Inc. Call Options Transaction History
Vr Adviser, LLC
- $505 Million
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ORIC
# of Institutions
146Shares Held
91.8MCall Options Held
1.03MPut Options Held
10.1K-
Nextech Invest, Ltd. Zurich, V87.16MShares$68.2 Million13.76% of portfolio
-
Viking Global Investors LP6.57MShares$62.6 Million0.21% of portfolio
-
Nextech Invest Ag5.29MShares$50.3 Million7.95% of portfolio
-
Black Rock Inc. New York, NY4.83MShares$46 Million0.0% of portfolio
-
Sr One Capital Management, LP4.51MShares$43 Million16.43% of portfolio
About Oric Pharmaceuticals, Inc.
- Ticker ORIC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,576,700
- Market Cap $377M
- Description
- ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...